Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. Takeda sets date for shareholder EGM over acquisition of Shire
  2. The problem with drug patents: can a new global approach help?
  3. AbbVie and Sandoz resolve Humira biosimilar patent dispute
  4. Ionis partners with Roche to advance new antisense drug
  5. Amazon and PillPack: an unstoppable pharmacy force?

Company A-Z

Latest Content

November’s top stories

Sobi has signed agreements to acquire the rights to AstraZeneca’s Synagis medicine in the US for an upfront payment of $1.5bn, and Takeda Pharmaceutical has received a conditional approval from the EC for the $62bn proposed acquisition of Irish biopharmaceutical company Shire. wraps up key headlines from November 2018.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top